MTOR and hypertrophic cardiomyopathy: Screening shows that these pathways mainly involve Complement and coagulation cascades, IL-17 signaling pathway, Toll-like receptor signaling pathway, Hypertrophic cardiomyopathy (HCM), Legionellosis, Dilated cardiomyopathy (DCM), Pathways in cancer, EGFR tyrosine kinase inhibitor resistance, FoxO signaling pathway, mTOR signaling pathway (Fig. 6D).